A study to detect the biomarkers which indicate efficacy of rituximab in patients treated for neuro-immunological diseases.
Phase of Trial: Phase II
Latest Information Update: 09 Sep 2015
At a glance
- Drugs Rituximab (Primary)
- Indications Autoimmune diseases of the nervous system
- Focus Biomarker; Pharmacodynamics
- 09 Sep 2015 New trial record